What Happened
- A landmark study published in Nature (February 2026) by Northwestern University researchers has demonstrated that the human brain continues to generate new neurons in the hippocampus even in people in their 80s — a process called adult hippocampal neurogenesis (AHN).
- "SuperAgers" — adults over 80 whose memory performance equals that of people in their 50s — produce two to two-and-a-half times more new neurons than typical older adults and Alzheimer's disease patients of similar age.
- The study analysed profiles of 355,997 nuclei using multiomic single-cell sequencing across post-mortem hippocampi from four cohorts: young adults, aged adults without cognitive impairment, SuperAgers, and Alzheimer's disease patients.
- Alzheimer's disease (AD) disrupts this renewal process early: even in preclinical AD (before clinical symptoms appear), early alterations in chromatin accessibility of neurogenic cells are observed, with further reduction in immature neurons in full AD.
- The findings challenge the long-held neuroscientific assumption that neurogenesis effectively ceases in adulthood, opening new avenues for dementia prevention and treatment.
Static Topic Bridges
Adult Hippocampal Neurogenesis (AHN) — The Science
For most of the 20th century, neuroscience held that the adult brain could not generate new neurons — that we are born with all the neurons we will ever have. This dogma was overturned by research in the 1990s showing that the hippocampus — the brain region critical for memory consolidation and spatial navigation — generates new neurons throughout life in mammals, including humans. This process is called adult hippocampal neurogenesis (AHN).
- Hippocampus: A seahorse-shaped structure in the medial temporal lobe; involved in memory formation, learning, and spatial navigation; one of the first regions damaged in Alzheimer's disease
- AHN: New neurons arise from neural stem cells (NSCs) in the subgranular zone (SGZ) of the hippocampal dentate gyrus; these immature neurons mature and integrate into existing neural circuits
- Function of new hippocampal neurons: Pattern separation (distinguishing between similar memories), emotional regulation, cognitive flexibility, and contextual learning
- Research method: The Nature 2026 study used single-cell multiomics — simultaneously measuring gene expression (RNA-seq) and chromatin accessibility (ATAC-seq) at the level of individual cells — in 355,997 nuclei from post-mortem brain tissue
- SuperAger definition: Adults over age 80 who score at or above the mean performance of adults in their 50s on standardised episodic memory tests
Connection to this news: The study directly quantifies the relationship between AHN rate and cognitive resilience — proving that SuperAgers' exceptional memory is linked to sustained high neurogenesis, not just preserved existing neurons.
Brain-Derived Neurotrophic Factor (BDNF) and Its Role
Brain-Derived Neurotrophic Factor (BDNF) is a protein in the brain that acts as a molecular "fertiliser" for neurons — it promotes the survival, growth, differentiation, and maintenance of neurons. BDNF is particularly critical for hippocampal neurogenesis and synaptic plasticity (the strengthening of connections between neurons that underlies learning and memory). Research consistently shows that BDNF levels decline with age and are significantly lower in Alzheimer's disease patients.
- BDNF: A member of the neurotrophin family; binds to TrkB receptors on neurons; activates signalling pathways that promote neuronal survival (PI3K/Akt) and synaptic plasticity (MAPK/ERK)
- BDNF and Alzheimer's: Reduced BDNF expression is found in the hippocampus and cortex of AD patients; BDNF decline may precede symptom onset; amyloid-beta (Aβ) plaques and tau tangles (the two hallmarks of AD) both suppress BDNF production
- BDNF boosters (lifestyle): Aerobic exercise is the most potent known stimulator of BDNF; intermittent fasting, learning new skills, social engagement, and adequate sleep also increase BDNF
- Therapeutic potential: Gene therapy delivering BDNF to the hippocampus has shown promise in preventing neuron death and improving memory in animal models of Alzheimer's
- Connection to neurogenesis: BDNF is one of the key growth factors that promotes the survival and maturation of newly generated hippocampal neurons; low BDNF → reduced AHN → cognitive decline
Connection to this news: The study's finding that Alzheimer's disrupts neurogenesis aligns mechanistically with known BDNF deficits in AD — suggesting that restoring BDNF signalling could be a therapeutic approach to preserving neurogenic capacity and cognitive resilience.
Alzheimer's Disease — India's Dementia Burden
India is increasingly confronted with a growing dementia and Alzheimer's burden driven by population ageing. A 2023 nationwide study estimated that 7.4% of Indians aged 60 and above live with dementia — approximately 8.8 million individuals. With India's elderly population projected to reach 319 million by 2050, the dementia burden is expected to increase dramatically, placing pressure on healthcare systems and families.
- Estimated dementia prevalence in India: 8.8 million individuals (as of 2023 study); higher in women and in rural areas
- Alzheimer's disease: Accounts for 60-70% of all dementia cases globally; characterised by accumulation of amyloid-beta plaques and neurofibrillary tau tangles in the brain
- India-specific risk factors: High prevalence of vascular risk factors (diabetes, hypertension, obesity) that accelerate dementia onset; lower education levels and social isolation are additional risk factors
- Preclinical AD: The study's finding that neurogenesis disruption begins in preclinical AD (before symptoms) opens possibilities for early biomarker detection
- National Programme for Mental Health (NPMH): India's policy framework for mental health, including dementia; currently underserved for dementia-specific care
- Research gap: India lacks a comprehensive national dementia registry; most data is from state-level or institution-based studies
Connection to this news: The Nature 2026 study's insight — that Alzheimer's disrupts neurogenesis early — is directly relevant to India's dementia challenge, suggesting that identifying and protecting neurogenic capacity in midlife could be a public health strategy to reduce future dementia burden.
Key Facts & Data
- Study source: Nature, February 2026; Northwestern University
- Method: Multiomic single-cell sequencing of 355,997 nuclei from post-mortem hippocampi
- SuperAger neurogenesis rate: 2 to 2.5 times higher than typical older adults and AD patients
- SuperAger definition: Adults over 80 with episodic memory equal to or better than adults in their 50s
- Alzheimer's disruption: Chromatin accessibility changes in neurogenic cells present even in preclinical AD
- India's dementia burden: ~8.8 million people aged 60+ with dementia (7.4% prevalence); 2023 nationwide estimate
- BDNF: Key neurotrophin for hippocampal neurogenesis; reduced in Alzheimer's; boosted by aerobic exercise
- Hippocampus: First brain region damaged in Alzheimer's; seat of AHN in adult humans
- India's elderly population: ~319 million projected by 2050; implies dramatic increase in dementia cases
- Aerobic exercise: Most potent known lifestyle stimulator of BDNF and adult neurogenesis